Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.

doi:10.1016/j.bmc.2021.116117

Paper

Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.

Published Apr 2, 2021 · Ming Sun, Jiaxing Zhao, Qing Mao

Bioorganic & medicinal chemistry

Q2 SJR score

15

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

The optimized compound, 2-(3-cyano-4-isopentoxy)phenylpyrimidine-4-ol, effectively reduces serum uric acid levels at an oral dose of 30 mg/kg, making it a promising therapy for hyperuricemia and gout.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.

References

Citations